Publications

Wave gradient background

Journal Articles

  1. Ezzati A, Golzar A, Afraz AS. Topography of the motion aftereffect with and without eye movements. Journal of Vision. 2008; PMID: 19146324.
  2. Ezzati A, Khadjevand F, Zandvakili A, Abbassian A. Higher-level motion detection deficit in Parkinson’s disease. Brain Res. 2010 PMID: 20083093.
  3. Ezzati A, Zimmerman ME, Katz MJ, Lipton RB. Hippocampal correlates of depression in healthy elderly adults.  Hippocampus. 2013 PMID: 23939871.
  4. Ezzati A, Jiang J, Katz MJ, Sliwinski MJ, Zimmerman ME, Lipton RB.  Validation of the Perceived Stress Scale in a community sample of older adults.  International J Geriatric Psychiatry. 2014 PMID: 24302253.
  5. Ezzati A, Zimmerman ME, Katz MJ, Sundermann EE, Smith JL, Lipton ML, Lipton RB. Hippocampal subfields differentially correlate with chronic pain in older adults. Brain Res. 2014 PMID: 24878607.
  6. Ezzati A, Katz MJ, Lipton ML, Lipton RB, Verghese J.The association of brain structure with gait velocity in older adults: a quantitative volumetric analysis of brain MRI.  Neuroradiology. 2015; PMID: 25921321.
  7. Katz MJ, Derby CA, Wang C, Sliwinski MJ, Ezzati A, Zimmerman ME, Zwerling JL, Lipton RB. Influence of Perceived Stress on Incident Amnestic Mild Cognitive Impairment: Einstein Aging Study.  Alzheimer Dis Associated Disorder. 2016 PMID: 26655068
  8. Zimmerman ME, Ezzati A, Katz MJ, Lipton ML, Brickman AM, Sliwinski MJ, Lipton RB. Perceived Stress Is Differentially Related to Hippocampal Subfield Volumes among Older Adults.  PLoS One. 2016; PMID: 27144832.
  9. Mitchell MB, Shirk SD, McLaren DG, Dodd JS, Ezzati A, Ally BA, Atri A.  Recognition of faces and names: multimodal physiological correlates of memory and executive function.  Brain Imaging Behavior. 2016 PMID: 26116280.
  10. Ezzati A, Katz MJ, Lipton ML, Zimmerman ME, Lipton RB. Hippocampal volume and cingulum bundle fractional anisotropy are independently associated with verbal memory in older adults.  Brain Imaging Behavior.  PMID: 26424564;
  11. Ezzati A, Katz MJ, Zammit AR, Lipton ML, Zimmerman ME, Sliwinski MJ, Lipton RB. Differential association of left and right hippocampal volumes with verbal and spatial memory in older adults.  Neuropsychologia. 2016 PubMed PMID: 27542320
  12. Eslami V, Katz MJ, White RS, Sundermann E, Jiang JM, Ezzati A, Lipton RB. Pain Intensity and Pain Interference in Older Adults: Role of Gender, Obesity and High-Sensitivity C-Reactive Protein.  Gerontology. 2017; PMID: 27486843.
  13. Zammit AR, Ezzati A, Zimmerman ME, Lipton RB, Lipton ML, Katz MJ. Roles of hippocampal subfields in verbal and visual episodic memory.  Behavioral Brain Res. 2017; PMCID: PMC6343125.
  14. Shirk SD, McLaren DG, Bloomfield JS, Powers A, Mitchell MB, Ezzati A, Ally BA, Atri A. Inter-Rater Reliability of Preprocessing EEG Data: Impact of Subjective Artifact Removal on Associative Memory Task ERP Results.  Front Neurosci.  2017. PubMed PMID: 28670264; PubMed Central PMCID: PMC5472725.
  15. Ezzati A, Wang C, Lipton RB, Altschul D, Katz MJ, Dickson DW, Derby CA.Association Between Vascular Pathology and Rate of Cognitive Decline Independent of Alzheimer’s Disease Pathology.  J Am Geriatric Soc. 2017 PubMed PMID: 28407205
  16. Zammit AR, Ezzati A, Katz MJ, Zimmerman ME, Lipton ML, Sliwinski MJ, Lipton RB.The association of visual memory with hippocampal volume. PLoS One. 2017; PMID: 29117260
  17. Ezzati A, Rundek T, Verghese J, Derby CA. Transcranial Doppler and Lower Extremity Function in Older Adults: Einstein Aging Study.  J American Geriatric Society. 2017 Dec;65(12):2659-2664. PubMed PMID: 29130477;
  18. Zammit AR, Hall CB, Katz MJ, Muniz-Terrera G, Ezzati A, Bennett DA, Lipton RB. Class-Specific Incidence of All-Cause Dementia and Alzheimer’s Disease: A Latent Class Approach.  J Alzheimer’s Dis. 2018; PMID: 30282367.
  19. Ezzati A, Wang C, Katz MJ, Derby CA, Zammit AR, Zimmerman ME, Pavlovic JM, Sliwinski MJ, Lipton RB. The Temporal Relationship between Pain Intensity and Pain Interference and Incident Dementia.  Current Alzheimer Res. 2019; PMID: 30543173.
  20. Zammit AR, Muniz-Terrera G, Katz MJ, Hall CB, Ezzati A, Bennett DA, Lipton RB. Subtypes Based on Neuropsychological Performance Predict Incident Dementia: Findings from the Rush Memory and Aging Project.  J Alzheimer’s Dis. PMID: 30507576.
  21. Ezzati A, Katz MJ, Derby CA, Zimmerman ME, Lipton RB. Depressive Symptoms Predict Incident Dementia in a Community Sample of Older Adults: Results From the Einstein Aging Study.  J Geriatric Psychiatry Neurol. 2019 PubMed PMID: 30630387.
  22. Ezzati A, Zammit AR, Katz MJ, Derby CA, Zimmerman ME, Lipton RB. Health-related Quality of Life, Cognitive Performance, and Incident Dementia in a Community-based Elderly Cohort.  Alzheimer Dis Associated Disorder. 2019 PubMed PMID: 31135451.
  23. Ezzati A, Zammit AR, Lipton ML, Lipton RB The relationship between hippocampal volume, chronic pain, and depression in older adults.  Psychiatry Res Neuroimaging. 2019; PMID: 31112826.
  24. Zammit AR, Hall CB, Bennett DA, Ezzati A, Katz MJ, Muniz-Terrera G, Lipton RB. Neuropsychological latent classes at enrollment and postmortem neuropathology.  Alzheimer’s & Dementia. 2019; PMID: 31420203.
  25. Ezzati A, Zammit AR, Harvey DJ, Habeck C, Hall CB, Lipton RB. Optimizing Machine Learning Methods to Improve Predictive Models of Alzheimer’s Disease.  J Alzheimer’s Dis. 2019 PMID: 31476152.
  26. Hyun J, Hall CB, Sliwinski MJ, Katz MJ, Wang C, Ezzati A, Lipton RB. Effect of Mentally Challenging Occupations on Incident Dementia Differs Between African Americans and Non-Hispanic Whites.  J Alzheimer’s Dis. 2020; PMID: 32417772
  27. Ezzati A, Zammit AR, Habeck C, Hall CB, Lipton RB. Detecting biological heterogeneity patterns in ADNI  mild cognitive impairment based on volumetric MRI.  Brain Imaging Behavior. 2010 PMID: 31104279.
  28. Ezzati A, Harvey DJ, Habeck C, Golzar A, Qureshi IA, Davatzikos C, Lipton RB Predicting Amyloid-β Levels in Amnestic Mild Cognitive Impairment Using Machine Learning Techniques. J Alzheimer’s Dis. 2020; PMID: 31884486
  29. Ezzati A, Lipton RB Machine Learning Predictive Models Can Improve Efficacy of Clinical Trials for Alzheimer’s Disease. J Alzheimer’s Dis. 2020; PMID: 31985462
  30. Lam S, Lipton RB, Harvey JH, Zammit AR, Ezzati A White matter hyperintensities and cognition across different Alzheimer’s biomarker profiles. J American Geriatrics Society. 2021, PMID: 33891712
  31. Lou C, Habes M, Illenberger NA, Ezzati A, Lipton RB, Shaw PA, Stephens-Shields AJ, Akbari H, Doshi J, Davatzikos C, Shinohara RT. Leveraging machine learning predictive biomarkers to augment the statistical power of clinical trials with baseline magnetic resonance imaging. Brain Communications. 2021, PMID: 34806001
  32. Ezzati A, Zammit AR, Lipton RB. Comparing Performance of Different Predictive Models in Estimating Disease Progression in Alzheimer Disease. Alzheimer Dis Assoc Disord. 2021. PMID: 34393191
  33. Ezzati A, Abdulkadir A, Jack CR, Thompson PM, Harvey DJ, Truelove-Hill M, Davatzikos C, Lipton RB Predictive value of Alzheimer’s ATN biomarker profiles in estimating disease progression in Alzheimer’s dementia. Alzheimer’s & Dementia, 2021. PMID: 34870371
  34. Grober E, Papp KV, Rentz DM, Sperlin RA, Johnson KA, Amariglio RE, Lipton RB, Ezzati A Neuroimaging correlates of Stages of Objective Memory Impairment (SOMI) system Alzheimer’s & Dementia: (Amst). 2021, PMID: 35005192
  35. Petersen KK, Grober E, Lipton RB, Sperling RA, Buckley RF, Aisen PS, Ezzati A Impact of sex and APOE ε4 on the association of cognition and hippocampal volume in clinically normal, amyloid positive adults. Alzheimer’s Dementia (Amst). 2022 PMID: 35155730
  36. Ezzati A, Fanning K, Buse D, Pavlovic J, Reed M, Lipton R Predictive models for determining treatment-response to non-prescription acute medications in migraine: Results from the American Migraine Prevalence and Prevention (AMPP) Study Headache, 2022, PMID: 35546653.
  37. Ezzati A, Davatzikos C, Wolk DA, Hall CB, Habeck C, Lipton RB. Application of predictive models in boosting power of Alzheimer’s disease clinical trials: A post hoc analysis of phase 3 solanezumab trials. Alzheimer’s Dementia (N Y). 2022. PubMed PMID: 35310531; PubMed Central PMCID: PMC8919041.
  38. Rubin-Norowitz M, Lipton RB, Petersen K, Ezzati A. Association of Depressive Symptoms and Cognition in Older Adults Without Dementia Across Different Biomarker Profiles.  J Alzheimer’s Dis. 2022 Jun 28; PMID: 35786653; PubMed Central PMCID: PMC9723980.
  39. Grober E, Lipton RB, Sperling RA, Papp KV, Johnson KA, Rentz, Aisen PA, Ezzati A Associations of Stages of Objective Memory Impairment (SOMI) with Amyloid PET and Structural MRI: The A4 Study. Neurology, 2022 Mar 29; PMID: 35197359; PubMed Central PMCID: PMC8967421.
  40. Petersen KK, Lipton RB, Grober E, Davatzikos C, Sperling RA, Ezzati A. Predicting Amyloid Positivity in Cognitively Unimpaired Older Adults: A Machine Learning Approach Using the A4 Clinical Trial Data. Neurology, 2022 Jun 14, Epub 2022 Apr 25; PMID: 35470142; PubMed Central PMCID: PMC9231843.
  41. Ezzati A, Buse DC, Fanning KM, Reed ML, Martin VT, Lipton RB. Predictors of treatment-response to acute prescription medications in migraine: Results from the American Migraine Prevalence and Prevention (AMPP) Study.  Clinical Neurology Neurosurgery. 2022 Dec; Epub 2022 Nov 3. PubMed PMID: 36395587.
  42. Petersen KK, Ezzati A, Lipton RB, Gordon BA, Hassenstab J, Morris JC, Grober E. Associations of Stages of Objective Memory Impairment with Cerebrospinal Fluid and Neuroimaging Biomarkers of Alzheimer’s Disease.  J Prev Alzheimers Dis. 2023; PubMed PMID: 36641615; PubMed Central PMCID: PMC9841119.
  43. Ezzati A, Fanning KM, Reed ML, Lipton RB.  Predictors of treatment-response to caffeine combination products, acetaminophen, acetylsalicylic acid (aspirin), and nonsteroidal anti-inflammatory drugs in acute treatment of episodic migraine. Headache, 2023, PMID: 35546653.
  44. Grober E, Petersen KK, Lipton RB, Hassenstab J, Morris JC, Gordon BA, Ezzati A Association of Stages of Objective Memory Impairment With Incident Symptomatic Cognitive Impairment in Cognitively Normal Individuals.  Neurology. 2023 PMID: 37076305; PubMed Central PMCID: PMC10259282.
  45. Wang C, Nester CO, Chang K, Rabin LA, Ezzati A, Lipton RB, Katz MJ. Tracking cognition with the T-MoCA in a racially/ethnically diverse older adult cohort. Alzheimers Dement (Amst). 2023 PMID: 36950700; PMCID: PMC10026378.
  46. Nallapu BT, Petersen KK, Lipton RB, Grober E, Sperling RA, Ezzati A. Association of Alcohol Consumption with Cognition in Older Population: The A4 Study. J Alzheimers Dis. 2023; PMID: 37182868.
  47. Skampardoni I, Nasrallah IM, Abdulkadir A, Wen J, Melhem R, Mamourian E, Erus G, Doshi J, Singh A, Yang Z, Cui Y, Hwang G, Ren Z, Pomponio R, Srinivasan D, Govindarajan ST, Parmpi P, Wittfeld K, Grabe HJ, Bülow R, Frenzel S, Tosun D, Bilgel M, An Y, Marcus DS, LaMontagne P, Heckbert SR, Austin TR, Launer LJ, Sotiras A, Espeland MA, Maruff P, Fripp J, Johnson SC, Morris JC, Albert MS, Bryan RN, Yaffe K, Völzke H, Ferrucci L, Benzinger TLS, Ezzati A, Shinohara RT, Habes M, Wolk D, Shou H, Nikita K, Davatzikos C. Genetic and Clinical Correlates of AI-Based Brain Aging Patterns in Cognitively Unimpaired Individuals.  JAMA Psychiatry. PubMed PMID: 38353984
  48. Nallapu BT, Petersen KK, Lipton RB, Davatzikos C, Ezzati A. Plasma Biomarkers as Predictors of Progression to Dementia in Individuals with Mild Cognitive Impairment. J Alzheimers Dis. PMID: 38393899.
  49. Skampardoni I, Nasrallah IM, Abdulkadir A, Wen J, Melhem R, Mamourian E, Erus G, Doshi J, Singh A, Yang Z, Cui Y, Hwang G, Ren Z, Pomponio R, Srinivasan D, Govindarajan ST, Parmpi P, Wittfeld K, Grabe HJ, Bülow R, Frenzel S, Tosun D, Bilgel M, An Y, Marcus DS, LaMontagne P, Heckbert SR, Austin TR, Launer LJ, Sotiras A, Espeland MA, Masters CL, Maruff P, Fripp J, Johnson SC, Morris JC, Albert MS, Bryan RN, Yaffe K, Völzke H, Ferrucci L, Benzinger TLS, Ezzati A, Shinohara RT, Fan Y, Resnick SM, Habes M, Wolk D, Shou H, Nikita K, Davatzikos C. Genetic and Clinical Correlates of AI-Based Brain Aging Patterns in Cognitively Unimpaired Individuals. JAMA Psychiatry. 2024 May 1;81(5):456-467. doi: 10.1001/jamapsychiatry.2023.5599. PMID: 38353984; PMCID: PMC10867779.
  50. Schwedt TJ, Pradhan AA, Oshinsky ML, Brin MF, Rosen H, Lalvani N, Charles A, Ashina M, Do TP, Burstein R, Gelfand AA, Dodick DW, Pozo-Rosich P, Lipton RB, Ailani J, Szperka CL, Charleston L 4th, Digre KB, Russo AF, Buse DC, Powers SW, Tassorelli C, Goadsby PJ; Headache Research Priorities Working Group Members. The headache research priorities: Research goals from the American Headache Society and an international multistakeholder expert group. Headache. 2024 Sep;64(8):912-930. doi: 10.1111/head.14797. Epub 2024 Aug 16. PMID: 39149968.
  51. Shewale AR, Poh W, Reed ML, Liu J, Cadiou F, Ezzati A, Burslem K, Manthena S, Lipton RB. Ubrogepant users’ real-world experience: Patients on ubrogepant, characteristics and outcomes (UNIVERSE) study. Headache. 2024 Nov-Dec;64(10):1244-1252. doi: 10.1111/head.14839. Epub 2024 Sep 26. PMID: 39324611.
  52. Nallapu BT, Petersen KK, Demirsoy I, Lipton RB, Davatzikos C, Rabin L, Sajjadi SA, Ezzati A. A weakly‐supervised, MRI‐guided clustering of cognitive decline: A post‐hoc analysis of the EXPEDITION‐3 clinical trial. Alzheimers Dement. 2025 Jan 3;20(Suppl 3):e090535. doi: 10.1002/alz.090535. PMCID: PMC11709581.
  53. Petersen KK, Nallapu BT, Demirsoy I, Lipton RB, Grober E, Rabin L, Ghanbarian E, Ezzati A. Investigating heterogeneity of cognitive and functional decline using Subtype and Stage Inference machine learning. Alzheimers Dement. 2025 Jan 3;20(Suppl 3):e091898. doi: 10.1002/alz.091898. PMCID: PMC11710631.
  54. Petersen, K.K., Nallapu, B.T., Demirsoy, I., Lipton, R.B., Grober, E., Morris, J.C., Hassenstab, J.J., Gordon, B.A. and Ezzati, A., Supervised clustering of MRI measures informed by incident cognitive impairment via aggregated survival model SHAP values. Alzheimer’s Dement., 2025 Jan 9(Suppl 3):e091898 . https://doi.org/10.1002/alz.089947

Conference Presentations

2024

  1. A Ezzati, K Petersen, B Nallapu, R Lipton
    CSF levels of proinflammatory and anti-inflammatory cytokines as predictors of cognitive decline across Alzheimer’s disease spectrum
    2024 American Academy of Neurology (AAN)
  2. A Ezzati, K Fanning, A Urani, F Cadiou, R Lipton
    A Comparison of Headache Assessment via Digital Platform in United States (HeAD-US) and American Migraine Prevalence and Prevention (AMPP) Studies
    2024 American Academy of Neurology (AAN)
  3. A Ezzati, K Fanning, A Urani, F Cadiou, RB. Lipton
    Navigating the Acute Migraine Treatment Landscape: Real-World Insights from the Headache Assessment via a Digital platform in United States (HeAD-US) Study
    2024 American Headache Society
  4. I Demirsoy, E Ghanbarian, EK Seng, RB Lipton, A Ezzati
    Patterns of Healthcare Utilization for Migraine in the United States: Results from the All of Us Research Program
    2024 American Headache Society

2023

  1. A Ezzati, KK Petersen K, E Seng-Tamaccio E, P Goadsby P, D Buse D, RB Lipton
    A Data-Driven Approach to Assess Clinical Heterogeneity in Migraine: Results of the American Migraine Prevalence and Prevention (AMPP) Study
    2023 American Headache Society (AHS)
  2. RB Lipton, AG De La Garza, C Wang, CA Derby, MJ Katz, MJ Sliwinski, A Ezzati
    The Association of Blood-based biomarkers and Cognitive Change as Measured by Ecologically Sensitive Digital Biomarkers.
    2023 Alzheimer’s Association International Conference (AAIC)
  3. KK Petersen, B Nallapu, RB Lipton, A Ezzati
    Impact of sex and ApoE4 on the longitudinal association of plasma ptau-181 and NFL with cognitive decline in non-demented older adults
    2023 Alzheimer’s Association International Conference (AAIC)
  4. B Nallapu, KK Petersen, RB Lipton, A Ezzati
    Predicting cognitive decline in short-term as a viable method to improve recruitment in clinical trials of Alzheimer’s Disease
    2023 Alzheimer’s Association International Conference (AAIC)
  5. KK Petersen, B Nallapu, E Grober, C Davatzikos, RB Lipton, A Ezzati
    Developing Integer-based Risk Scores for Predicting the Risk of Incident Cognitive Impairment in Cognitively Normal Older Adults
    2023 Alzheimer’s Association International Conference (AAIC)
  6. CT Udeh-Momoh, A Ezzati, Mila Kivipelto, et al
    A Multi-National Collaboration to Assess the Feasibility and Sustainability of Implementing Multimodal Brain Health Promotion Strategies in Sub-Saharan Africa (The AFRICA-FINGERS Project)
    2023 Alzheimer’s Association International Conference (AAIC)
  7. KK Petersen, B Nallapu, E Grober, RB Lipton, A Ezzati
    Predictive Value of CSF Inflammatory Biomarkers in Alzheimer’s disease
    2023 Alzheimer’s Association International Conference (AAIC)
  8. KK Petersen, B Nallapu, E Grober, C Davatzikos, RB Lipton, A Ezzati
    Predicting of β‐amyloid Positivity Using Integer‐based Risk Scores with Blood‐based Biomarkers
    2023 Alzheimer’s Association International Conference (AAIC)
  9. A Ezzati, K Petersen, B Nallapu, R Lipton
    Using Predictive Models to Reduce Heterogeneity in Alzheimer’s Disease Clinical Trials
    2023 American Academy of Neurology (AAN)

2022

  1. E Grober, RB Lipton, RA Sperling, KV Papp, KA Johnson, DM Rentz, A Ezzati
    Associations of Stages of Objective Memory Impairment with Amyloid PET and Structural MRI: The A4 Study
    2022 American Academy of Neurology (AAN)
  2. A Ezzati, KM Fanning, ML Reed, RB Lipton
    Identifying predictors of treatment-response to different OTC medication classes in acute migraine
    2022 American Headache Society (AHS)
  3. E Grober, KK Petersen, J Hassenstab, JC Morris, RB Lipton, A Ezzati
    Stages of Objective Memory Impairment (SOMI) predicts incident cognitive impairment: Results from the Knight ADRC
    2022 Alzheimer’s Association International Conference (AAIC)
  4. C Wang, CO Nester, K Chang, LA Rabin, A Ezzati, RB Lipton, MJ Katz
    Modality Matters for Health Disparity Groups on the Montreal Cognitive Assessment (MoCA): Findings from the Einstein Aging Study (EAS)
    2022 Alzheimer’s Association International Conference (AAIC)
  5. B Nallapu, KK Petersen, RB Lipton, D Harvey, A Ezzati
    Comparison of Plasma-based Biomarkers and Cognitive Assessments in predicting progression of MCI to Dementia
    2022 Alzheimer’s Association International Conference (AAIC)
  6. B Nallapu, KK Petersen, RB Lipton, D Harvey, A Ezzati
    Association of Cognition with Alcohol Consumption in Cognitively Unimpaired Older Adults: Results from the A4 study
    2022 Alzheimer’s Association International Conference (AAIC)
  7. KK Petersen, E Grober, RB Lipton, B Nallapu, A Ezzati
    Assessing Risk of Incident Cognitive Impairment Using Stages of Objective Memory Impairment (SOMI) and Cerebrospinal Fluid
    2022 Alzheimer’s Association International Conference (AAIC)
  8. KK Petersen, RB Lipton, B Nallapu, A Ezzati
    MRI-guided Clustering of Alzheimer’s Disease patients: A post-hoc analysis of Phase 3 Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease
    2022 Alzheimer’s Association International Conference (AAIC)
  9. A Ezzati, KK Petersen, B Nallapu, C Davatzikos, D Wolk, LA Rabin, C Habeck, CB Hall, RB Lipton
    Targeting the Correct Population for Trials: A Post-hoc Analysis of Trial of Solanezumab for Mild Dementia Due to Alzheimer’s disease.
    2022 Alzheimer’s Association International Conference (AAIC)
  10. A Ezzati, R Lipton, K Petersen
    Simple risk scores for the prediction of brain β-amyloid and tau status in older adults with mild cognitive impairment
    2022 American Academy of Neurology (AAN)
  11. A Ezzati, K Petersen, B Nallapu, R Lipton
    Using Predictive Models to Reduce Heterogeneity in Alzheimer’s Disease Clinical Trials
    2022 American Academy of Neurology (AAN)

2021

  1. S Lam, RB Lipton, DJ Harvey, AR Zammit, A Ezzati
    The association between white matter hyperintensities and cognitive function among individuals with different amyloid, tau, and neurodegeneration biomarker profiles
    2021 AAIC Neuroscience Next
  2. A Ezzati, RB Lipton
    Predictors of cerebral tauopathy across the Alzheimer disease spectrum.
    2021 AAIC Neuroscience Next
  3. A Ezzati, D Harvey, K Petersen, R Lipton
    Predictors of cerebral tauopathy in individuals with normal cognition and amnestic mild cognitive impairment (aMCI)
    2021 American Academy of Neurology (AAN)
  4. S Lam, R Lipton, D Harvey, A Zammit, A Ezzati
    Association Between White Matter Disease and Cognitive Function is Independent of Alzheimer’s Disease Biomarker Profile
    2021 American Academy of Neurology (AAN)
  5. A Ezzati, K Fanning, D Buse, J Pavlovic, M Reed, R Lipton
    Use of predictive modeling to determine treatment-response to OTC Medications in Acute Migraine: Results from the American Migraine Prevalence and Prevention Study (AMPP)
    2021 American Academy of Neurology (AAN)
  6. M Rubin-Norowitz, R Lipton, K Petersen, A Ezzati
    The Relationship Between Depressive Symptoms and Cognitive Function in Non-Demented Older Adults Across Different Alzheimer’s Disease Biomarker Profiles
    2021 American Academy of Neurology (AAN)
  7. A Ezzati, DC Buse, ML Reed, JM Pavlovic, CE Armand, KM Fanning, RB Lipton
    Predicting treatment-response to prescription acute migraine medications
    2021 American Headache Society (AHS)
  8. A Ezzati, PM Thompson, C Davatzikos, DJ Harvey, RB Lipton
    Predicting the risk of incident dementia in older adults: The ADNI-Dementia risk score
    2021 Alzheimer’s Association International Conference (AAIC)
  9. K Petersen, E Grober, RB Lipton, RA Sperling, RF Buckley, A Ezzati
    Cognition and hippocampal volume in amyloid positive clinically normal adults: Results from the A4 study
    2021 Alzheimer’s Association International Conference (AAIC)

2020 and earlier

  1. A Ezzati, A Golzar, SR Afraz
    Topographic map of the motion aftereffect
    2005 European Conference on Visual Perception (ECVP)
  2. M Adibi, A Ezzati
    The effect of flashing stimuli on the motion perception of remote moving objects
    2005 European Conference on Visual Perception (ECVP)
  3. A Ezzati, A Golzar, SR Afraz
    Topographic map of motion aftereffect after saccade
    2017 European Conference on Visual Perception (ECVP)
  4. A Daneshmand, A Ezzati
    Dynamic shift of visual receptive fields in the motion-detection hierarchy
    2008 European Conference on Visual Perception (ECVP)
  5. A Ezzati, F Khadjevand, A Zandvakili, AH Abbassian
    Debility in higher level motion detection in Parkinson’s disease: a clue for attentional rigidity?
    2009 European Conference on Visual Perception (ECVP)
  6. S Attarian, A Ezzati, S Talehy-Moineddin, M Sanayei
    Retinotopic organization of high-level aftereffects
    2009 European Conference on Visual Perception (ECVP)
  7. A Ezzati, MB Mitchel, SD Shirk, DG Mclaren, BA Ally, A Atri
    Neural Correlates of Face-Name Encoding Using Simultaneous Eye-Tracking and ERP
    2012 American Neurological Association Conference (ANA)
  8. A Ezzati, M Zimmerman, M Katz, R Lipton
    The Link between Recent Stress and Hippocampal Measures in Healthy Elderly Adults
    2013 American Academy of Neurology (AAN)
  9. A Ezzati, M Katz, M Zimmerman, R Lipton
    Hippocampal Correlates of Depressive Symptoms in Nondemented Elderly Adults
    2013 American Academy of Neurology (AAN)
  10. A Ezzati, C Derby, M Katz, M Zimmerman, R Lipton, D Cabral, T Rundek
    Transcranial Doppler cerebral blood flow velocity and cognitive function: Results from the Einstein Aging Study
    2013 Alzheimer’s Association International Conference (AAIC)
  11. M Katz, C Wang, A Ezzati, M Sliwinski, M Zimmerman, C Derby, R Lipton
    Stress and risk of amnestic mild cognitive impairment: Results from the Einstein Aging Study
    2013 Alzheimer’s Association International Conference (AAIC)
  12. C Derby, A Ezzati, T Rundek, MJ Katz, RB Lipton, J Verghese
    Transcranial Doppler Ultrasound (TCD) Cerebral Blood Flow is Associated with Gait Velocity: Einstein Aging Study
    2013 The Gerontological Society of America (GSA)
  13. ME Zimmerman, A Brickman, A Ezzati, MJ Katz, RB Lipton
    Stress, Neuroimaging, and Cognitive Aging
    2013 The Gerontological Society of America (GSA)
  14. MJ Katz, CA Derby, C Wang, MJ Sliwinski, A Ezzati, ME Zimmerman, RB Lipton
    Influence of Perceived Stress on Incident Amnestic Mild Cognitive Impairment
    2015 Alzheimer’s Association International Conference (AAIC)
  15. V Eslami, M Katz, R White, E Sundermann, J Jiang, A Ezzati, R Lipton
    Pain Intensity and Pain Interference in Older Adults: Role of Gender, Obesity and Inflammation
    2015 American Academy of Neurology (AAN)
  16. A Ezzati, MJ Katz, ML Lipton, RB Lipton
    Total intracranial volume and current total brain volume are linked to level of pain in older adults.
    American Academy of Neurology (AAN)
  17. ME Zimmerman, AM Brickman, A Ezzati, MJ Katz, MJ Sliwinski, RB Lipton
    Stress and white matter hyperintensities in nondemented older adults
    2015 Alzheimer’s Association International Conference (AAIC)
  18. A Ezzati, MJ Katz, MJ Sliwinski, AM Brickman, ME Zimmerman, RB Lipton
    Correlates of memory function in older adults: The importance of white matter hyperintensities and hippocampal volume
    2015 Alzheimer’s Association International Conference (AAIC)
  19. A Ezzati, A Brickman, M Zimmerman, M Katz, C Derby, M Lipton, RB Lipton
    Relationship of White Matter Hyperintensity and Cortical Volume with Gait Velocity in Older Adults
    2016 American Academy of Neurology (AAN)
  20. A Ezzati, C Wang, R Lipton, D Altschul, M Katz, D Dickson, C Derby
    Vascular Pathology Is Associated with Rate of Cognitive Decline Independent of AD Pathology (Einstein Aging Study)
    2016 American Academy of Neurology (AAN)
  21. A Ezzati, M Katz, M Lipton, R Lipton
    Hippocampal atrophy in older adults with chronic pain is associated with higher levels of depressive symptoms
    2017 American Academy of Neurology (AAN)
  22. A Ezzati, C Wang, A Zammit, M Katz, M Zimmerman, C Derby, R Lipton
    The temporal relationship between pain intensity and interference and incident dementia: a community-based prospective study
    2017 American Academy of Neurology (AAN)
  23. S Attarian, M Janakiram, A Ezzati, RA Gucalp
    Dimethyl sulfoxide (DMSO) cryopreserved stem cell infusion-related seizures: A single institution experience.
    2017 American Society of Oncology (ASCO)
  24. ME Zimmerman, MJ Katz, A Ezzati, ML Lipton, AM Brickman, RB Lipton
    White Matter Hyperintensities Modify the Relationship between Hippocampal Volume and Verbal Memory in Older Adults without Dementia
    2017 Alzheimer’s Association International Conference (AAIC)
  25. A Ezzati, MJ Katz, ME Zimmerman, CA Derby, RB Lipton
    Health-Related Quality Of Life Measures From Sf-36 Health Survey Predict Incident Dementia In Older Adults
    2018 Alzheimer’s Association International Conference (AAIC)
  26. A Ezzati, MJ Katz, CA Derby, ME Zimmerman, RB Lipton
    Depressive symptoms predict incident dementia in a community sample of older adults
    2018 Alzheimer’s Association International Conference (AAIC)
  27. A Ezzati, A Zammit, D Harvey, C Habeck, N Mesgarani, C Hall, R Lipton
    Predicting Clinical Course in Persons with Mild Cognitive Impairment using structural MRI.
    2019 American Academy of Neurology (AAN)
  28. A Ezzati, AR Zammit, J Hyun, RB Lipton
    The signal and the noise in Alzheimer’s disease: can machine learning methods improve our predictions?
    2019 Alzheimer’s Association International Conference (AAIC)
  29. 2020 J Hyun, CB Hall, MJ Katz, A Ezzati, RB Lipton
    The association between mentally challenging occupations and incident dementia differs between non-Hispanic whites and African-Americans.
    2019 Alzheimer’s Association International Conference (AAIC)
  30. A Ezzati, R Lipton
    Machine Learning Models Can Improve Efficiency of Alzheimer’s Disease Clinical Trials.
    2020 American Academy of Neurology (AAN)
  31. A Ezzati, D Harvey, A Golzar, C Habeck, I Qureshi, A Zammit, RB Lipton
    Risk estimation of Amyloid Beta positivity on PET with Cognitive, CSF Biomarkers, volumetric MRI, APOE, and Demographic information.
    2020 American Academy of Neurology (AAN)
  32. M Truelove‐Hill, G Erus, R Pomponio, A Ezzati, J Doshi, M Habes, C Davatzikos
    A predictive, modeling‐based screening tool to enrich amyloid beta positivity in a cognitively normal sample
    2020 Alzheimer’s Association International Conference (AAIC)
  33. A Ezzati, C Davatzikos, DA Wolk, PS Aisen, RB Lipton
    Is it time to use predictive models to boost power of Alzheimer’s disease clinical trials? A post‐hoc analysis of phase 3 Solanezumab trials
    2020 Alzheimer’s Association International Conference (AAIC)
  34. A Ezzati, DJ Harvey, C Davatzikos, M Truelove‐Hill, C Davatzikos, RB Lipton
    Prediction of longitudinal clinical outcomes of MCI population using Alzheimer’s AT [N] biomarker profiling: Can machine learning methods improve our predictions?
    2020 Alzheimer’s Association International Conference (AAIC)